This month Endocrine News is tackling a topic that’s been in the news a lot lately — obesity — albeit with a different twist. Our cover story by Melissa Mapes discusses the added hazard that being overweight causes in patients with dementia (“Heavy Mettle,” p. 17). Each is problematic, but treating these two conditions concurrently...
As each New Year is celebrated at the stroke of midnight on December 31st, hopes are high for what the coming year will bring. We are all well aware of the myriad changes that go into effect this month as the Affordable Care Act becomes a way of life for physicians, patients, insurance companies, and...
We’ve taken a slightly different approach with the December issue, coincidentally just in time for the high caloric intake of the holidays as we give you a doubleheader with two features on the much publicized and often controversial topic of surgery to address obesity. Gastric bypass surgery has been well known for its ability to...
This month’s cover story features the controversial topic of testosterone therapy and how it has been perceived by some — both inside and outside the medical community — as a new path to the legendary “fountain of youth.” In “Testosterone Replacement Therapy… Is It the New Fountain of Youth?” (page 14), Glenda Fauntleroy uncovers some...
This month’s cover story deals with the thorny topic of why many kidney transplants fail. Th e topic is prickly because there’s more than one reason for this failure. One of the chief culprits is the patient, who often goes off his or her meds for one reason or another. Another culprit is Medicare, which...
While the September issue’s cover story deals exclusively with pediatric endocrinology, two of this month’s features are plumbed from deep within recent research studies from Th e Endocrine Society’s own Journal of Clinical Endocrinology & Metabolism (JCEM). Th e research literature is where much of the latest advances are presented, so we felt a certain...
As you can see, our cover story is on the advances made in technology surrounding the monitoring and treatment of diabetes. Unfortunately, the product we originally had on the cover—a Medtronic Paradigm insulin pump—had an adverse event report from the Food & Drug Administration after the manufacturer issued a safety notification to all users and...
Another ENDO has passed and as I’m sure you noticed if you made it to San Francisco, it was a roaring success, with attendance records being broken almost every single day. Th e sessions were nothing short of amazing in terms of the amount of information that was shared. For me, it was a great...
